NxGen MDx

The AI engine Fit Assessment

Beta

NxGen MDx enhances women's health through advanced genetic screening and counseling, improving research, diagnosis, and care.

Blurb

A women’s health company delivering highly accurate and precise genetic screening results.

HQ Location

United States

Founded

2012

Employees

101 - 250

Total funding raised

Not available

Last Funding Event

Not available

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
  • Genomic and Genetic Testing

Provider of genetic disease screenings intended to offer a comprehensive assessment of risk. The company's genetic screening offers a variety of genetic screens for inherited diseases such as Cystic Fibrosis, Spinal Muscular Atrophy, and Fragile X Syndrome and genetics counselors and customer service, enabling patients to have a comprehensive assessment of the true risk.